On October 14, 2026, Merck Animal Health, part of Merck & Co., Inc. based in Rahway, New Jersey, announced that it will host scientific symposia at the 2026 World Small Animal Veterinary Association (WSAVA) Congress in Warsaw, Poland. The focus will be on the latest advancements in treating canine allergic dermatitis, parasite protection, and protocols for preventing infectious diseases.

Read More

Delair Bolis, associate vice president of Global Companion Animals at MSD Animal Health, stated, "Sharing our latest innovations at WSAVA reflects how MSD Animal Health continues to help drive transformative veterinary medicine for companion animals and those who care for them. We are committed to advancing companion animal health through effective treatment and prevention strategies."

Attendees are invited to visit the MSD Animal Health booth (#04) to learn about significant developments in veterinary medicine, including the launch of NOBIVAC® NXT Feline vaccines, the new NUMELVI® product, enhanced parasite protection with BRAVECTO® Injectable, and a celebration of the AFYA Program’s 30-year mission towards global rabies elimination.

Key symposia will include:

**Breaking the Itch Cycle: Diagnosis, Treatment, and Prevention of Allergic Dermatitis**

Scheduled for Tuesday, October 13, 2026, from 13:15 to 14:15 in Parallel Hall 5, the symposium will feature presenters Linda Horspool, Patrick Hensel, Galia Sheinberg, and Dawid Janczak. This session aims to provide a comprehensive clinical framework for managing allergic dermatitis, including stepwise diagnostic procedures, targeted anti-inflammatory treatments, and the importance of year-round flea control for patient comfort.

**Retrovirus Reality Check: Cracking the Code of FeLV & FIV**

Taking place on Wednesday, October 14, 2026, from 12:45 to 13:45 in Parallel Hall 4, this session will be led by Melissa Bourgeois and Petra Cerna. It will cover feline retrovirus infections, focusing on actionable diagnosis and management strategies for feline immunodeficiency virus (FIV) and feline leukemia virus (FeLV). The presentation will also introduce the NOBIVAC NXT Feline vaccine, highlighting its innovative RNA particle technology designed to improve feline preventive care.